Business Context and Reporting Period
Company: The Estée Lauder Companies Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2008 (First Quarter of Fiscal 2009)
Business Overview: The Company manufactures, markets, and sells beauty products in skin care, makeup, fragrance, and hair care categories distributed in over 140 countries. The Company operates as a single reportable segment but evaluates performance by product category and geographic region.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2009 (Sep 30, 2008) | Q1 2008 (Sep 30, 2007) |
|---|---|---|
| Net Sales | $1,903.5 | $1,710.1 |
| Gross Profit | $1,403.4 | $1,254.3 |
| Gross Margin | 73.7% | 73.3% |
| Operating Income | $92.5 | $77.9 |
| Operating Margin | 4.8% | 4.5% |
| Net Earnings | $51.1 | $39.1 |
| Diluted EPS | $0.26 | $0.20 |
| Cash and Cash Equivalents | $328.8 | $211.4 |
| Total Debt | $1,431.9 | N/A |
| Net Cash Used in Operating Activities | $(196.2) | $(132.8) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 11% ($193.4 million) year-over-year. Organic growth (excluding currency) was 10%. Growth was driven by Skin Care (+16%) and Makeup (+12%) categories. Asia/Pacific sales surged 24%, followed by Europe, Middle East & Africa (+16%).
- Profitability: Operating income rose 19% to $92.5 million. Gross margin improved 40 basis points due to favorable product mix and lower promotional activity, partially offset by higher inventory obsolescence charges. Operating expense margin increased slightly to 68.9% due to foreign exchange losses and IT infrastructure costs.
- Cash Flow: Operating cash flow turned negative at $(196.2) million, an increase in outflows compared to the prior year. This was primarily due to timing of payments for advertising/merchandising, higher income tax payments, and increased inventory levels to support forecasted sales.
- Debt: Total debt increased to $1.43 billion, with short-term debt rising significantly to $349.9 million (up from $118.7 million at June 30, 2008) due to increased commercial paper issuance.
Guidance, Outlook, and Risks
- Economic Outlook: Management notes that recent economic challenges and uncertainties in key markets (including the U.S.) may adversely impact consumer demand and retailer financial strength. The dramatic strengthening of the U.S. dollar post-September 30, 2008, is expected to negatively impact results in the second quarter and potentially the full fiscal year.
- Product Strategy: Continued focus on new product launches (e.g., Perfectionist, Cyber White, Sensuous) to drive growth, though new launches may cannibalize existing product sales.
- Acquisitions: Completed acquisitions of Applied Genetics Incorporated Dermatics (AGI) and Aveda wholesale/retail distribution businesses in Q1 2009, totaling $57.7 million.
- Risks: Key risks include foreign currency fluctuations, competitive pressures in the fragrance category, retail industry consolidation, and potential disruptions in supply chain or manufacturing facilities.
- Legal: Ongoing litigation regarding the Blydenburgh landfill; management believes the outcome will not have a material adverse effect.
Investor Verification Checklist
- Currency Impact: Verify the magnitude of the U.S. dollar strengthening impact on Q2 and full-year guidance, as management flagged this as a significant headwind.
- Operating Cash Flow: Investigate the specific timing of the $196.2 million operating cash outflow to determine if it is a seasonal anomaly or a structural shift in working capital management.
- Inventory Levels: Review the increase in inventory ($1,048.4 million vs. $987.2 million prior quarter) and the associated obsolescence charges to assess potential future write-down risks.
- Short-Term Debt: Monitor the $299.7 million in outstanding commercial paper and the company's ability to refinance at prevailing rates given market volatility.
- Segment Performance: Confirm the sustainability of the 24% sales growth in Asia/Pacific and the 70% operating income increase in that region.